Summary report of the Working Group on Mammalian Germ Cell Tests.
The two tests considered by the Working Group were the mammalian germ cell cytogenetic assay and the rodent dominant lethal test. It was agreed that both tests were mainly used for identification of germ cell hazards, however, that the commonly applied protocol of the dominant lethal assay often supplied information for hazard characterization such as sensitivity of particular developmental stages of male germ cells. No particular species or strains were indicated. Concurrent solvent controls were regarded as indispensable for both tests. In the discussion of the mammalian germ cell cytogenetic assay, harmonization was obtained to a large extent with the cytogenetic bone marrow assay regarding the number of animals (5), the number of cells analyzed per animal (200), the highest exposure dose (MTD) and sampling times (twice within 24 and 48 h after dosing). However, it was pointed out that only the single acute exposure was adequate for the mammalian germ cell cytogenetic assay. Furthermore, it was stated that only structural chromosome aberrations could be analyzed and that it was not informative to score polyploidies or aneuploidies. In the discussion of the rodent dominant lethal test, it was stated that the assay was generally performed with treated males, however, increasing concern about female specific effects required that a protocol for female dominant lethal testing should be developed and validated. Acute and subacute treatment schedules were considered equally acceptable. It was regarded as highly important that the entire male germ cell development from meiosis to mature sperm was covered in the test protocol either by the appropriate mating schedules after single dosing or by subchronic dosing during the respective period. Postimplantation loss, preimplantation loss and fertility rate were the main parameters to be assessed in the rodent dominant lethal tests. It was agreed that the size of the experiment depended on the spontaneous frequency of dead implants, the mating scheme and the statistical design of the experiment.
Adler
I D
ID
GSF-Institut für Säugetiergenetik, Oberschleissheim, Germany.
Shelby
M D
MD
Bootman
J
J
Favor
J
J
Generoso
W
W
Pacchierotti
F
F
Shibuya
T
T
Tanaka
N
N
D000782:Aneuploidy; D000818:Animals; D002869:Chromosome Aberrations; D006224:Cricetinae; D003627:Data Interpretation, Statistical; D004305:Dose-Response Relationship, Drug; D005260:Female; D005313:Fetal Death; D005804:Genes, Lethal; D005854:Germ Cells / Q000187:drug effects*; D017408:Guidelines as Topic; D008297:Male; D051379:Mice; D009152:Mutagenicity Tests / Q000379:methods / Q000592:standards*; D009153:Mutagens / Q000633:toxicity; D051381:Rats; D015203:Reproducibility of Results; D012107:Research Design; D012737:Sex Factors; D013091:Spermatogenesis / Q000187:drug effects
D009153:Mutagens